Antipas, Leonardo A.
HRN: 21-53-10 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/10/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/10/2022
07/16/2022
IV
600 Mg
Q8H
Cellulitis, Right Leg
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes